People: CareFusion Corp (CFN.N)
CFN.N on New York Stock Exchange
34.13USD
4:03pm EDT
34.13USD
4:03pm EDT
Price Change (% chg)
$0.03 (+0.09%)
$0.03 (+0.09%)
Prev Close
$34.10
$34.10
Open
$34.13
$34.13
Day's High
$34.35
$34.35
Day's Low
$34.08
$34.08
Volume
237,700
237,700
Avg. Vol
356,450
356,450
52-wk High
$35.61
$35.61
52-wk Low
$23.79
$23.79
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Kieran Gallahue |
49 | 2011 | Chairman of the Board, Chief Executive Officer |
James Hinrichs |
45 | 2010 | Chief Financial Officer |
Vivek Jain |
40 | 2011 | President - Procedural Solutions |
Thomas Leonard |
44 | 2011 | President - Medical Systems |
Joan Stafslien |
48 | 2010 | Executive Vice President, Chief Compliance Officer, General Counsel, Secretary |
Roger Marchetti |
54 | 2011 | Executive Vice President - Human Resources |
Donald Abbey |
46 | 2012 | Executive Vice President - Quality, Regulatory and Medical Affairs |
Gordon La Fortune |
55 | 2012 | Executive Vice President - EMEA/APAC Commercial Operations and Global Infusion Disposables |
Jean Maschal |
61 | 2009 | Senior Vice President, Chief Accounting Officer, Controller |
Philip Francis |
66 | Non-Employee Independent Director | |
Robert Friel |
57 | Non-Employee Independent Director | |
Jacqueline Kosecoff |
63 | Non-Employee Independent Director | |
J. Michael Losh |
66 | Non-Employee Independent Presiding Director | |
Gregory Lucier |
48 | Non-Employee Independent Director | |
Edward Miller |
69 | Non-Employee Independent Director | |
Michael O'Halleran |
62 | Non-Employee Independent Director | |
Robert Wayman |
67 | Non-Employee Independent Director |
Biographies
| Name | Description |
|---|---|
Kieran Gallahue |
Mr. Kieran T. Gallahue is Chairman of the Board, Chief Executive Officer of CareFusion Corporation., since January 29, 2011. Prior to joining the company in January 2011, he was the president, chief executive officer and a director of ResMed Inc., a medical device firm serving the sleep disordered breathing and respiratory markets. Mr. Gallahue joined ResMed in January 2003 as president and chief operating officer of the Americas and was promoted to ResMed’s president in September 2004. He served in that role until he was named president, chief executive officer and a director of ResMed in January 2008. Prior to joining ResMed, from January 1998 to December 2002, he held positions of increasing responsibility at Nanogen, Inc., a DNA research and medical diagnostics company, including president and chief financial officer. Prior to 1998, Mr. Gallahue held various marketing, sales and financial positions within Instrumentation Laboratory, The Procter & Gamble Company and General Electric Company. He is a director of Volcano Corporation. During the prior five years, Mr. Gallahue also served on the board of directors of ResMed. |
James Hinrichs |
Mr. James F. Hinrichs is Chief Financial Officer of CareFusion Corp., since November 29, 2010. He previously served as the company Senior Vice President, Global Customer Support, from January 2010 through December 2010, when he was promoted to his current position. From January 2009 through January 2010, Mr. Hinrichs served as the company Senior Vice President, Controller, a position he assumed up to the spinoff from Cardinal Health. Mr. Hinrichs joined Cardinal Health in February 2004 as Vice President, Investor Relations, and since then served in several financial leadership positions, including as Chief Financial Officer of the former Clinical Technologies and Services, Healthcare Supply Chain Services, and Clinical and Medical Products segments. From June 2007 to June 2008, Mr. Hinrichs also served as Controller for Cardinal Health. Before joining Cardinal Health, Mr. Hinrichs spent 12 years in a variety of finance and marketing positions at Merck & Co. |
Vivek Jain |
Mr. Vivek Jain is President - Procedural Solutions of CareFusion Corporation. Until August 2011, Mr. Jain served as President, Medical Technologies and Services. Prior to the spinoff, he served as Executive Vice President—Strategy and Corporate Development of Cardinal Health since August 2007. Prior to joining Cardinal Health, from May 2006 to August 2007 he served as Senior Vice President/Head of Healthcare Strategy, Business Development and M&A for the Philips Medical Systems business of Koninklijke Philips Electronics N.V., an electronics company. He was an investment banker at J.P. Morgan Securities, Inc., an investment banking firm, from July 1994 to April 2006. His last position with J.P. Morgan was as Managing Director/Co-Head of Global Healthcare Investment Banking from April 2002 to April 2006. |
Thomas Leonard |
Mr. Thomas J. Leonard is President - Medical Systems of CareFusion Corporation. Until August 2011, Mr. Leonard served as President, Dispensing Technologies. Prior to the spinoff, he served as Senior Vice President and General Manager, Clinical Services of Cardinal Health since June 2008. Prior to joining Cardinal Health, from June 2005 to June 2008, he was Senior Vice President and General Manager, Ambulatory Solutions of McKesson Corporation, a healthcare services company. From July 2000 to June 2005 he was Executive Vice President of Operations at Picis, Inc., a provider of acute care products and services. |
Joan Stafslien |
Ms. Joan Stafslien is Executive Vice President, Chief Compliance Officer, General Counsel, Secretary of CareFusion Corporation. Ms. Stafslien was previously the company Executive Vice President, General Counsel and Secretary, and effective June 2010, assumed the additional role of Chief Compliance Officer. Prior to the spinoff, she served as Senior Vice President and General Counsel, Clinical and Medical Products of Cardinal Health since July 2008. She was Senior Vice President and General Counsel, Clinical Technologies and Services of Cardinal Health, from August 2004 to July 2008. Ms. Stafslien served as Deputy General Counsel and Assistant General Counsel of ALARIS Medical Systems, Inc. (“Alaris”) from March 1999 to July 2004, when Cardinal Health acquired Alaris. From May 1998 to February 1999, she served as Senior Corporate Counsel to Alaris. Prior to joining Alaris, she was an associate with the law firms of Brobeck, Phleger & Harrison LLP and Luce, Forward, Hamilton & Scripps LLP. |
Roger Marchetti |
Mr. Roger Marchetti is Executive Vice President - Human Resources of Carefusion Corp., since July 2011. Prior to joining the company in July 2011, he was the Senior Vice President, Human Resources and Information Management of Amylin Pharmaceuticals, a biopharmaceutical company, since July 2007. He previously served as Senior Vice President, Human Resources and Corporate Services of Amylin from November 2005 to July 2007. From July 2002 to October 2005, he served as Vice President, Human Resources for Guidant Corporation, a medical device company. Prior to this role, he served as Vice President, Finance and Information Systems, Guidant Europe, Middle East, Africa, and Canada, since the beginning of 2001. From 1999 through 2000, he served as Vice President, Human Resources for Guidant’s Vascular Intervention group, and served as Guidant’s first Corporate Controller and Chief Accounting Officer from 1994 to 1999. Prior to joining Guidant, he spent over five years in various finance roles with Eli Lilly. From 1980 to 1986, he was on the audit staff of the accounting firm Touche Ross & Co. (currently Deloitte & Touche LLP). |
Donald Abbey |
Mr. Donald Abbey is Executive Vice President - Quality, Regulatory and Medical Affairs of Carefusion Corp. Until November 2011, Mr. Abbey served as the company Senior Vice President, Quality and Regulatory Affairs. Prior to the spinoff, Mr. Abbey served as Senior Vice President, Quality and Regulatory Affairs — Clinical and Medical Products of Cardinal Health, since March 2007. Prior to joining Cardinal Health, from February 2006 to March 2007, Mr. Abbey served as Vice President, Regulatory Affairs and Quality Assurance for the Critical Care division of Respironics, Inc., a medical device firm serving the global sleep and respiratory markets. Previously, he held a number of leadership roles within the healthcare industry, including general manager of Welch Allyn’s cardiopulmonary business; vice president of Quality Assurance and Regulatory Affairs for Protocol Systems, Inc.; and director of Quality Assurance for Heartstream, Inc. |
Gordon La Fortune |
Mr. Gordon La Fortune is Executive Vice President - EMEA/APAC Commercial Operations and Global Infusion Disposables of Carefusion Corp. From August 2011 to July 2012, Mr. LaFortune served as the company Executive Vice President, International Commercial Operations. Until August 2011, Mr. LaFortune was the company Senior Vice President and General Manager, Infusion. Prior to the spinoff, Mr. LaFortune served as President of the Infection Prevention business of Cardinal Health, from November 2004 to December 2008. From June 2001 to November 2004, Mr. LaFortune was President, International for Cardinal Health, and from February 1999 to June 2001, Mr. LaFortune was Vice President and General Manager for Cardinal Health Canada. Before joining Cardinal Health, Mr. LaFortune was Vice President and General Manager for Allegiance Healthcare Canada, which was acquired by Cardinal Health in February 1999. Mr. LaFortune also held various marketing, sales and operations positions at Allegiance and Baxter International, a manufacturer and marketer of healthcare products and services, prior to Baxter’s spinoff of the Allegiance business in 1996. |
Jean Maschal |
Ms. Jean Maschal is Senior Vice President, Chief Accounting Officer, Controller of CareFusion Corp. Ms. Maschal was previously the company Vice President and Chief Accounting Officer, and effective December 2009, was promoted to her current position. From August 2008 to June 2009, she served as Vice President, Finance and Controller — Clinical and Medical Products of Cardinal Health. Ms. Maschal was Vice President, Finance and Controller — Clinical Technologies and Services of Cardinal Health from April 2007 to August 2008. From July 2006 to March 2007, she served as Vice President, Clinical Technologies and Services Controller of Cardinal Health. She was Vice President, Finance for Alaris from July 2004, when Cardinal Health acquired Alaris, until July 2006. Prior to the acquisition of Alaris by Cardinal Health, she served as Vice President, Finance and Corporate Controller of Alaris, since March 2002, and as Assistant Controller of Alaris from January 1999 to February 2002. Prior to joining Alaris, she was a senior auditor with the accounting firm of Pricewaterhouse LLP. |
Philip Francis |
Mr. Philip L. Francis is Non-Employee Independent Director of CareFusion Corporation. Mr. Francis most recently served as executive chairman of PetSmart, Inc., a specialty pet retailer, from June 2009 until his retirement in January 2012. He previously served as chairman and chief executive officer of PetSmart from 1999 until his appointment as executive chairman. Mr. Francis is a director of PetSmart, Inc. and the lead director of SUPERVALU INC. During the prior five years, Mr. Francis also served on the board of Cardinal Health. |
Robert Friel |
Mr. Robert F. Friel is Non-Employee Independent Director of CareFusion Corporation. Mr. Friel has served as president and chief executive officer of PerkinElmer, Inc., a focused on improving the health and safety of people and the environment, since February 2008. He has also served as a director of PerkinElmer since January 2006, serving as vice chairman until he was appointed as chairman in April 2009. He joined PerkinElmer in 1999, serving as senior vice president and chief financial officer from February 1999 to October 2004, as executive vice president and chief financial officer from October 2004 to January 2006, as president of the Life and Analytical Sciences unit from January 2006 through August 2007, and as president and chief operating officer from August 2007 through February 2008. Mr. Friel is a director of Xylem Inc. During the prior five years, Mr. Friel also served on the boards of Fairchild Semiconductor International, Inc. and Millennium Pharmaceuticals, Inc. |
Jacqueline Kosecoff |
Dr. Jacqueline B. Kosecoff, Ph.D. is Non-Employee Independent Director of CareFusion Corporation. Dr. Miller is a professor of anesthesiology and critical care medicine at The Johns Hopkins University School of Medicine. He previously served as chief executive officer of Johns Hopkins Medicine, which encompasses The Johns Hopkins University School of Medicine and The Johns Hopkins Health System and Hospital, and as dean of the medical faculty of The Johns Hopkins University School of Medicine from January 1997 until his retirement in June 2012. Dr. Miller joined Johns Hopkins in 1994 as a professor and director of the department of anesthesiology and critical care medicine. Prior to joining Johns Hopkins, Dr. Miller held positions as a professor, researcher and clinician at various hospitals and academic institutions. He is a director of PNC Mutual Funds, Inc. During the prior five years, he also served on the board of PNC Alternative Strategies Fund LLC. |
J. Michael Losh |
Mr. J. Michael Losh is Non-Employee Independent Presiding Director of CareFusion Corporation. He most recently served as interim chief financial officer of Cardinal Health from July 2004 to May 2005. Previously, he was the chief financial officer of General Motors Corporation, an automobile manufacturer, from 1994 to 2000. He is a director of Prologis Inc., Aon Corporation, H.B. Fuller Company, Masco Corporation, and TRW Automotive Holdings Corporation. During the prior five years, Mr. Losh also served on the boards of AMB Property Corporation, Cardinal Health and Metaldyne Corporation. |
Gregory Lucier |
Mr. Gregory T. Lucier is Non-Employee Independent Director of CareFusion Corporation. Mr. Lucier has served as chairman and chief executive officer of Life Technologies Corporation, a biotechnology tools company, since November 2008 when Invitrogen Corporation and Applied Biosystems merged to form Life Technologies. Previously, he served as chief executive officer of Invitrogen Corporation from May 2003 to November 2008. |
Edward Miller |
Mr. Edward D. Miller, M.D. is Non-Employee Independent Director of CareFusion Corporation. Dr. Miller is a professor of anesthesiology and critical care medicine at The Johns Hopkins University School of Medicine. He previously served as chief executive officer of Johns Hopkins Medicine, which encompasses The Johns Hopkins University School of Medicine and The Johns Hopkins Health System and Hospital, and as dean of the medical faculty of The Johns Hopkins University School of Medicine from January 1997 until his retirement in June 2012. Dr. Miller joined Johns Hopkins in 1994 as a professor and director of the department of anesthesiology and critical care medicine. Prior to joining Johns Hopkins, Dr. Miller held positions as a professor, researcher and clinician at various hospitals and academic institutions. He is a director of PNC Mutual Funds, Inc. During the prior five years, he also served on the board of PNC Alternative Strategies Fund LLC. |
Michael O'Halleran |
Mr. Michael D. O'Halleran is Non-Employee Independent Director of CareFusion Corporation. Mr. O’Halleran has served as senior executive vice president of Aon Corporation, a provider of risk management, insurance and consulting services, since September 2004. From 1999 to 2004, Mr. O’Halleran served as president and chief operating officer of Aon Corporation. Mr. O’Halleran joined Aon in 1987 to lead its reinsurance division. Since that time, he has served in several management positions within the Aon group of companies including, since August 2007, as the executive chairman of Aon Benfield, the division of Aon Corporation that provides reinsurance and brokerage services. During the prior five years, Mr. O’Halleran served on the board of Cardinal Health. |
Robert Wayman |
Mr. Robert P. Wayman is Non-Employee Independent Director of CareFusion Corporation. Mr. Wayman served as chief financial officer of the Hewlett-Packard Company (“HP”), a computer and electronics company, from 1984 until his retirement in December 2006. He also served as executive vice president, finance and administration of HP from 1992 until his retirement after 37 years with the company. He served as interim chief executive officer of HP from February 2005 through March 2005. He is a director of Affymetrix, Inc. During the prior five years, Mr. Wayman also served on the boards of HP, Sybase, Inc. and Con-way, Inc. (formerly CNF, Inc.). |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Kieran Gallahue |
9,966,610 |
James Hinrichs |
3,310,990 |
Vivek Jain |
1,988,470 |
Thomas Leonard |
2,005,520 |
Joan Stafslien |
1,788,340 |
Roger Marchetti |
-- |
Donald Abbey |
-- |
Gordon La Fortune |
-- |
Jean Maschal |
-- |
Philip Francis |
-- |
Robert Friel |
-- |
Jacqueline Kosecoff |
-- |
J. Michael Losh |
-- |
Gregory Lucier |
-- |
Edward Miller |
-- |
Michael O'Halleran |
-- |
Robert Wayman |
-- |
As Of 29 Jun 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Kieran Gallahue |
0 | 0 |
James Hinrichs |
0 | 0 |
Vivek Jain |
0 | 0 |
Thomas Leonard |
0 | 0 |
Joan Stafslien |
0 | 0 |
Roger Marchetti |
0 | 0 |
Donald Abbey |
0 | 0 |
Gordon La Fortune |
0 | 0 |
Jean Maschal |
0 | 0 |
Philip Francis |
0 | 0 |
Robert Friel |
0 | 0 |
Jacqueline Kosecoff |
0 | 0 |
J. Michael Losh |
0 | 0 |
Gregory Lucier |
0 | 0 |
Edward Miller |
0 | 0 |
Michael O'Halleran |
0 | 0 |
Robert Wayman |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
STAFSLIEN JOAN B |
40,000 | $20.71 |
STAFSLIEN JOAN B |
6,999 | $25.09 |
STAFSLIEN JOAN B |
46,999 | $35.00 |
STAFSLIEN JOAN B |
380 | $25.09 |
STAFSLIEN JOAN B |
380 | $35.00 |
LOSH J MICHAEL |
50,000 | $25.01 |
LOSH J MICHAEL |
50,000 | $33.16 |
LA FORTUNE GORDON |
1,749 | $32.71 |
LA FORTUNE GORDON |
758 | $17.77 |
MASCHAL JEAN |
14,559 | $32.73 |
LA FORTUNE GORDON |
991 | $17.77 |
ABBEY DONALD M |
10,000 | $32.75 |
MASCHAL JEAN |
6,568 | $20.71 |
STAFSLIEN JOAN B |
21,857 | $32.67 |
STAFSLIEN JOAN B |
477 | $17.77 |
STAFSLIEN JOAN B |
690 | $17.77 |
GALLAHUE KIERAN T |
61,392 | $31.12 |
GALLAHUE KIERAN T |
126,676 | $0.00 |
LA FORTUNE GORDON |
87 | $0.00 |
LA FORTUNE GORDON |
87 | $0.00 |
MASCHAL JEAN |
89 | $0.00 |
MASCHAL JEAN |
89 | $0.00 |
LOSH J MICHAEL |
6,019 | $0.00 |
O HALLERAN MICHAEL D |
6,019 | $0.00 |
MILLER EDWARD D JR |
6,019 | $0.00 |

